Amended Statement of Ownership (sc 13g/a)
2020年1月25日 - 6:12AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment
No. 3)*
Aeon
Global Health Corp.
(Name
of Issuer)
Common
Stock, $0.001 par value
(Title
of Class of Securities)
00774U107
(CUSIP
Number)
December
31, 2019
(Date
of Event Which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
[_]
Rule 13d-1(b)
[X]
Rule 13d-1(c)
[_]
Rule 13d-1(d)
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
1.
|
|
NAMES
OF REPORTING PERSONS
Ibex
Investors LLC
|
|
|
2.
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see
instructions)
(a) ☐
(b) ☒
|
|
|
3.
|
|
SEC
USE ONLY
|
|
|
4.
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Colorado, USA
|
|
|
|
|
|
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
|
5.
|
|
SOLE
VOTING POWER
1,467,383
|
|
6.
|
|
SHARED
VOTING POWER
0
|
|
7.
|
|
SOLE
DISPOSITIVE POWER
1,467,383
|
|
8.
|
|
SHARED
DISPOSITIVE POWER
0
|
|
|
|
|
|
9.
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,467,383
|
|
|
10.
|
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see
instructions) ☐
|
|
|
11.
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
13.4%
|
|
|
12.
|
|
TYPE
OF REPORTING PERSON (see instructions)
OO
|
|
|
|
|
|
|
|
|
1.
|
|
NAMES
OF REPORTING PERSONS
Justin
B. Borus
|
|
|
2.
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see
instructions)
(a) ☐
(b) ☒
|
|
|
3.
|
|
SEC
USE ONLY
|
|
|
4.
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
USA
|
|
|
|
|
|
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
|
5.
|
|
SOLE
VOTING POWER
1,467,383
|
|
6.
|
|
SHARED
VOTING POWER
0
|
|
7.
|
|
SOLE
DISPOSITIVE POWER
1,467,383
|
|
8.
|
|
SHARED
DISPOSITIVE POWER
0
|
|
|
|
|
|
9.
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,467,383
|
|
|
10.
|
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see
instructions) ☐
|
|
|
11.
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
13.4%
|
|
|
12.
|
|
TYPE
OF REPORTING PERSON (see instructions)
IN
|
|
|
|
|
|
|
|
|
1.
|
|
NAMES
OF REPORTING PERSONS
Ibex
Microcap Fund LLLP
|
|
|
2.
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see
instructions)
(a) ☐
(b) ☒
|
|
|
3.
|
|
SEC
USE ONLY
|
|
|
4.
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware,
USA
|
|
|
|
|
|
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
|
5.
|
|
SOLE
VOTING POWER
1,466,550
|
|
6.
|
|
SHARED
VOTING POWER
0
|
|
7.
|
|
SOLE
DISPOSITIVE POWER
1,466,550
|
|
8.
|
|
SHARED
DISPOSITIVE POWER
0
|
|
|
|
|
|
9.
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,466,550
|
|
|
10.
|
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see
instructions) ☐
|
|
|
11.
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
13.4%
|
|
|
12.
|
|
TYPE
OF REPORTING PERSON (see instructions)
PN
|
|
|
|
|
|
|
|
|
1.
|
|
NAMES
OF REPORTING PERSONS
Lazarus
Macro Micro Partners LLLP
|
|
|
2.
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see
instructions)
(a) ☐
(b) ☒
|
|
|
3.
|
|
SEC
USE ONLY
|
|
|
4.
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware,
USA
|
|
|
|
|
|
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
|
5.
|
|
SOLE
VOTING POWER
833
|
|
6.
|
|
SHARED
VOTING POWER
0
|
|
7.
|
|
SOLE
DISPOSITIVE POWER
833
|
|
8.
|
|
SHARED
DISPOSITIVE POWER
0
|
|
|
|
|
|
9.
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
833
|
|
|
10.
|
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see
instructions) ☐
|
|
|
11.
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.00008%
|
|
|
12.
|
|
TYPE
OF REPORTING PERSON (see instructions)
PN
|
|
|
|
|
|
|
|
|
1.
|
|
NAMES
OF REPORTING PERSONS
Ibex
Investment Holdings LLC
|
|
|
2.
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see
instructions)
(a) ☐
(b) ☒
|
|
|
3.
|
|
SEC
USE ONLY
|
|
|
4.
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware,
USA
|
|
|
|
|
|
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
|
5.
|
|
SOLE
VOTING POWER
1,467,383
|
|
6.
|
|
SHARED
VOTING POWER
0
|
|
7.
|
|
SOLE
DISPOSITIVE POWER
1,467,383
|
|
8.
|
|
SHARED
DISPOSITIVE POWER
0
|
|
|
|
|
|
9.
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,467,383
|
|
|
10.
|
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see
instructions) ☐
|
|
|
11.
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
13.4%
|
|
|
12.
|
|
TYPE
OF REPORTING PERSON (see instructions)
OO
|
|
|
|
Item
1.
|
(a)
|
The
name of the issuer is Aeon Global Health Corp. (the “Issuer”).
|
|
(b)
|
The
principal executive offices of the Issuer are located at 2225 Centennial Drive, Gainesville,
GA 30504.
|
Item
2.
|
(a)
|
This
Schedule 13G (this “Statement” or this “Schedule 13G”)
is being filed by: (1) Justin B. Borus; (2) Ibex Investors LLC, a Colorado limited liability
company (the “Investment Manager”); (3) Ibex Microcap Fund LLLP, a
Delaware limited liability limited partnership (the “Fund”); (4) Lazarus
Macro Micro Partners LLLP, a Delaware limited liability limited partnership (“Macro
Micro Partners”); and (5) Ibex Investment Holdings LLC, a Delaware limited
liability company (“IM Holdings”) (all of the foregoing, collectively,
the “Reporting Persons”). The Fund and Macro Micro Partners are private
investment vehicles. The Fund and Macro Micro Partners directly beneficially own the
Common Stock (as defined below) reported in this Statement. The Investment Manager is
the investment manager and general partner of the Fund and Macro Micro Partners. IM Holdings
is the sole member of the Investment Manager. Justin B. Borus is the manager of the Investment
Manager and IM Holdings. Justin B. Borus, the Investment Manager and IM Holdings may
be deemed to beneficially own the Common Stock directly beneficially owned by the Fund
and Macro Micro Partners. Each Reporting Person disclaims beneficial ownership with respect
to any shares other than the shares directly beneficially owned by such Reporting Person.
|
|
(b)
|
The
principal business office of the Reporting Persons is c/o Ibex Investors LLC, 3200 Cherry
Creek South Drive, Suite 670, Denver, CO 80209.
|
|
(c)
|
For
citizenship information see Item 4 of the cover page of each Reporting Person.
|
|
(d)
|
This
Statement relates to the Common Stock, $0.001 par value per share (the “Common
Stock”).
|
|
(e)
|
The
CUSIP Number of the Common Stock is 00774U107.
|
Item
3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
[_] Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
(b)
|
[_] Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
(c)
|
[_] Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
(d)
|
[_] Investment
company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
(e)
|
[_] An
investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
[_] An
employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
[_] A
parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
[_] A
savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act
(12 U.S.C. 1813);
|
|
(i)
|
[_] A
church plan that is excluded from the definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
(j)
|
[_] A
non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
|
|
(k)
|
[_] Group,
in accordance with §240.13d-1(b)(1)(ii)(K).
|
If
filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:
Item
4. Ownership.
See
Items 5-9 and 11 on the cover page for each Reporting Person, and Item 2, which information is given as of the filing date of
this Schedule 13G and is also accurate as of the Event Date of December 31, 2019. The securities reported herein consist of 458,133
shares of Common Stock, 200,000 shares of Series D Preferred Stock that are convertible into 204,679 shares of Common Stock and
warrants to purchase 803,738 shares of Common Stock held by the Fund, and an additional 833 shares of Common Stock held by Macro
Micro Partners. The percentages of beneficial ownership contained herein are based on 9,915,064 shares of Common Stock outstanding
as of October 9, 2019, as reported by the Issuer in its Form 10-K filed on October 15, 2019.
Item
5. Ownership of Five Percent or Less of a Class.
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following: [_]
Item
6. Ownership of More than Five Percent on Behalf of Another Person.
Not
applicable.
Item
7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
Not
applicable.
Item
8. Identification and Classification of Members of the Group.
Not
applicable.
Item
9. Notice of Dissolution of Group.
Not
applicable.
Item
10. Certification.
(a) Not
applicable.
(b) Not
applicable.
|
(c)
|
By
signing below I certify that, to the best of my knowledge and belief, the securities
referred to above were not acquired and are not held for the purpose of or with the effect
of changing or influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction having that
purpose or effect, other than activities solely in connection with a nomination under
§240.14a-11.
|
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated:
January 24, 2020
Justin
B. Borus
Ibex
Investors LLC
Ibex
Microcap Fund LLLP
Lazarus
Macro Micro Partners LLLP
Ibex
Investment Holdings LLC
By: /s/
Justin B. Borus
Justin
B. Borus, for himself and as the Manager of each of IM Holdings and the Investment Manager (for itself and on behalf of the Fund
and Macro Micro Partners)
EXHIBIT
INDEX
|
Exhibit No.
|
Document
|
|
|
|
|
1
|
Joint
Filing Agreement
|
Exhibit
1
JOINT
FILING AGREEMENT
In
accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint
filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock,
par value 0.001 per share, of Aeon Global Health Corp., and further agree that this Joint Filing Agreement be included as an Exhibit
to such joint filing. In evidence thereof, the undersigned hereby execute this Agreement.
Dated:
January 24, 2020
Justin
B. Borus
Ibex
Investors LLC
Ibex
Microcap Fund LLLP
Lazarus
Macro Micro Partners LLLP
Ibex
Investment Holdings LLC
By: /s/
Justin B. Borus
Justin
B. Borus, for himself and as the Manager of each of IM Holdings and the Investment Manager (for itself and on behalf of the Fund
and Macro Micro Partners)
Aeon Global Health (CE) (USOTC:AGHC)
過去 株価チャート
から 4 2024 まで 5 2024
Aeon Global Health (CE) (USOTC:AGHC)
過去 株価チャート
から 5 2023 まで 5 2024
Real-Time news about Aeon Global Health Corporation (CE) (その他OTC): 0 recent articles
その他のAeon Global Health Corp.ニュース記事